Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases

被引：17
作者：
Erstad, Derek J. [1 ]
Taylor, Martin S. [2 ]
Qadan, Motaz [1 ]
Axtell, Andrea L. [1 ,3 ]
Fuchs, Bryan C. [1 ]
Berger, David L. [1 ]
Clancy, Thomas E. [4 ]
Tanabe, Kenneth K. [1 ]
Chang, David C. [1 ,3 ]
Ferrone, Cristina R. [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Codman Ctr Clin Effectiveness Surg, Boston, MA 02115 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF SURGERY | 2020年 / 220卷 / 06期
关键词：
Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Colorectal; Liver metastasis; Hepatectomy; Overall survival; Prognosis; LONG-TERM SURVIVAL; HEPATIC RESECTION; CANCER; TUMOR; BIOLOGY;
D O I：
10.1016/j.amjsurg.2020.05.003
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Background: The prognostic significance of the platelet (PLR) and neutrophil (NLR) to lymphocyte ratios for patients with resectable colorectal cancer liver metastases (CLM) was evaluated. Methods: Clinicopathologic data from patients who underwent hepatectomy for CLM at two tertiary care hospitals between 1995 and 2017 were collected. Blood counts were evaluated for prognostic significance. Results: 151 patients met inclusion criteria. The median age was 58 years, 44% were female, and 58% had synchronous metastases. Median number of liver metastases was 2, and 59% of patients underwent lobectomy or extended lobectomy. On multivariable analysis, NLR >5 (HR 2.46 [1.08-5.60 CI], p = 0.032), PLR > 220 (HR 2.10 [1.04-4.23 CI], p = 0.037), and greater than 2 liver metastases (HR 2.41 [1.06-5.45 CI], p = 0.035) were associated with reduced overall survival. Conclusions: PLR > 220 and NLR > 5 may have utility as preoperative prognostic markers for overall survival in patients with resectable CLM. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码：1579 / 1585
页数：7
相关论文
共 50 条
  • [21] Perioperative chemotherapy for resectable colorectal liver metastases: Where now?
    Jones, R. P.
    Malik, H. Z.
    Fenwick, S. W.
    Poston, G. J.
    EJSO, 2013, 39 (08): : 807 - 811
  • [22] Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC)
    Gawdi, Rohin
    Valenzuela, Cristian D.
    Moaven, Omeed
    Stauffer, John A.
    Del Piccolo, Nico R.
    Cheung, Tanto
    Corvera, Carlos U.
    Wisneski, Andrew D.
    Cha, Charles
    Shen, Perry
    Russell, Greg
    Zarandi, Nima
    Dourado, Justin
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (02) : 339 - 347
  • [23] The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development
    Sanchez-Salcedo, Pablo
    de-Torres, Juan P.
    Martinez-Urbistondo, Diego
    Gonzalez-Gutierrez, Jessica
    Berto, Juan
    Campo, Arantzazu
    Alcaide, Ana B.
    Zulueta, Javier J.
    LUNG CANCER, 2016, 97 : 28 - 34
  • [24] Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer
    Hong, Chuyuan
    Wei, Yisheng
    Jiang, Jianxin
    Zhao, Chuxiong
    Liang, Guojian
    Wang, Guoqiang
    Yang, Hui
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (02) : 168 - 174
  • [25] Assessment of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Patients with Temporal Lobe Epilepsy
    Baran, Oguz
    Korkmaz, Taha Sukru
    Kemerdere, Rahsan
    Akcil, Eren Fatma
    Yeni, Seher Naz
    Uzan, Mustafa
    Tanriverdi, Taner
    EPILEPSI, 2020, 26 (01): : 30 - 34
  • [26] Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia
    Zhu, Xiaoyu
    Zhou, Jia
    Zhu, Yu
    Yan, Feng
    Han, Xiaole
    Tan, Yunlong
    Li, Ran
    AUSTRALASIAN PSYCHIATRY, 2022, 30 (01) : 95 - 99
  • [27] Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases
    Halazun, K. J.
    Aldoori, A.
    Malik, H. Z.
    Al-Mukhtar, A.
    Prasad, K. R.
    Toogood, G. J.
    Lodge, J. P. A.
    EJSO, 2008, 34 (01): : 55 - 60
  • [28] Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis
    Chen, Feng-Lin
    Wang, Yan-Yan
    Liu, Wei
    Xing, Bao-Cai
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases
    Christopher P. Neal
    Vaux Cairns
    Michael J. Jones
    Muhammad M. Masood
    Gael R. Nana
    Christopher D. Mann
    Giuseppe Garcea
    Ashley R. Dennison
    Medical Oncology, 2015, 32
  • [30] Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
    Yoji Kishi
    Scott Kopetz
    Yun Shin Chun
    Martin Palavecino
    Eddie K. Abdalla
    Jean-Nicolas Vauthey
    Annals of Surgical Oncology, 2009, 16
12345